ZOLEDRONIC ACID ROLE IN SRES PREVENTION: AN ADVANTAGE FOR ALL PATIENTS WITH ADVANCED NSCLC AND BONE METASTASES?

被引：0
|
作者：
Del Signore, E. [1 ]
De Marinis, F. [2 ]
机构：
[1] San Camillo Forlanini High Specializat Hosp, Rome, Italy
[2] AO San Camillo Forlanini, Dept Lung Dis, Rome, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] Prevention of SREs in Patients with NSCLC: The Role of Zoledronic Acid
    Condemi, G.
    Panuccio, J.
    ONCOLOGY, 2009, 77 : 139 - 139
  • [2] Efficacy of zoledronic acid in the prevention of bone metastases in patients with locally advanced prostate cancer
    Musaev, T. N.
    Zeinalov, B. S.
    Kerimov, A. Kh.
    Guliev, F. A.
    Musaev, I. N.
    Alizade, A. M.
    Adzhalov, O. V.
    ONKOUROLOGIYA, 2011, 7 (01): : 62 - 65
  • [3] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [4] BONE METASTASES IN NSCLC: THE ANTIANGIOGENIC EFFECT OF ZOLEDRONIC ACID (ZA)
    Quirino, M.
    Orlandi, A.
    Quaranta, A.
    Strippoli, A.
    Cursio, O. E.
    Di Lascio, S.
    Amoruso, A.
    Basso, M.
    Cassano, A.
    Barone, C.
    LUNG CANCER, 2011, 71 : S32 - S32
  • [5] The role of zoledronic acid in cancer: Clinical studies in the treatment and prevention of bone metastases
    Coleman, RE
    Seaman, JJ
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 11 - 16
  • [6] Effect of the number of bone lesions on efficacy of zoledronic acid for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.
    Shirina, N.
    Coleman, R. E.
    Chen, Y. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 475S - 475S
  • [7] Symptomatic skeletal events (SSEs) versus skeletal- related events (SREs) in patients with advanced cancer and bone metastases treated with denosumab or zoledronic acid
    von Moos, R.
    Costa, L. A. M.
    Scagliotti, G.
    Sleeboom, H.
    Goldwasser, F.
    Hirsh, V.
    Spencer, A.
    Radcliffe, H-S.
    Niepel, D.
    Henry, D. H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] ZOLEDRONIC ACID AND TREATMENT OF BONE METASTASIS IN PATIENTS WITH ADVANCED LUNG CANCER (NSCLC AND SCLC)
    Longo, F.
    Del Signore, E.
    De Sanctis, R.
    Quadrini, S.
    Stumbo, L.
    Gori, B.
    De Filippis, L.
    Proietti, E.
    Minisola, S.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 258 - 258
  • [9] Osteonecrosis of the jaw in cancer patients with bone metastases treated with zoledronic acid: The focus is prevention
    Vormola, R.
    Ortega, C.
    Montemurro, F.
    Faggiuolo, R.
    Nanni, D.
    Goia, F.
    Aglietta, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI72 - XI72
  • [10] Recommendations for zoledronic acid treatment of patients with bone metastases
    Berenson, JR
    ONCOLOGIST, 2005, 10 (01): : 52 - 62
12345